Method for conservative management of parodentium

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dentistry. A method for the conservative treatment of parodontium involves applying a treatment wrap prepared of zinc oxide and zinc sulphate; applying the treatment wrap is preceded by a multiple irrigation of parodontium tissues with butol solution; the treatment wrap is prepared by adding zinc oxide powder and zinc sulphate powder into butol solution and mixing them to pasty consistency; dental tissues from the vestibular and oral surfaces in the neck region are covered with a gauze drain of the diameter of 1-4mm saturated with butol solution; parodentium and dental tissues covered with the gauze drain saturated with butol solution is coated with the treatment wrap.

EFFECT: using the method enables achieving optimum diffusion of the therapeutic preparation in the parodontium tissue and its prolonged effect on parodontal tissues, with providing haemostatic effect and adequate anti-inflammatory action.

2 ex

 

The invention relates to medicine, namely to the dentist, and can be used for conservative treatment of periodontitis.

The known method of conservative treatment of periodontal disease, which consists in the introduction of biomaterial injection method in the transition region of the folds of the upper and lower jaws, the biomaterial used a strain of diploid lung cells of a human embryo LAC-4(81), which is injected in the form of a cell suspension rate 5-7 procedures from 1 to 3 times per week at a dose per injection: 500-700 thousand to 1 million cells, depending on age [1].

The disadvantage of this method is that it does not provide a hemostatic effect, does not have sufficient anti-inflammatory effect through the use of a drug with a narrow spectrum of antimicrobial action, does not provide optimal diffusion of the drug into the tissues of the periodontium.

The known method of conservative treatment of periodontitis, in which the local effects of synergists in the form of an antiseptic triclosan and macrolide antibiotic spiramycin in inflamed periodontal tissues in the ratio of 1-2,5, with exposure times of 1 hour [2].

The disadvantage of this method is that it does not provide a hemostatic effect, does not have sufficient anti-inflammatory effective the om through the use of a drug with a narrow spectrum of antimicrobial action, provides optimal diffusion of the drug into the tissues of the periodontium. The method has a short action.

The known method of conservative treatment of periodontal disease, which consists in conducting curettage of periodontal pockets and antiseptic treatment drug "Forest balm" with its application to the area of inflammation in the amount of 0.05 to 0.2 grams and its introduction in periodontal pockets [3].

The disadvantage of this method is that it does not provide a hemostatic effect, does not have sufficient anti-inflammatory effect through the use of a drug with a narrow spectrum of antimicrobial action, does not provide optimal diffusion of the drug into the tissues of the periodontium. The method has a short action.

The known method of conservative treatment of periodontal disease, which is manufacturing and the imposition of the medical bandage on inflamed periodontal tissues, prepared on the basis of zinc oxide and zinc sulfate liquid dosage form [4].

The disadvantage of this method is that it does not provide a hemostatic effect, does not have sufficient anti-inflammatory effect through the use of a drug with a narrow spectrum of antimicrobial action, does not provide optimal diff is Ziya drug in periodontal tissues. This method is used for the prototype.

The aim of the invention are to provide a hemostatic effect sufficient anti-inflammatory action, optimal diffusion of the drug into the tissues of the periodontium, the prolonged effects of drugs on periodontal tissues.

This goal is achieved by the fact that before the imposition of medical bandages repeated irrigation of periodontal tissues with a solution of butala; medical bandage is made by adding a powder of zinc oxide and zinc sulfate in solution butola and blend them to a paste-like consistency; hard tissue of teeth with vestibular and oral surfaces in the cervical areas covered by torontoi diameter of 1-4 mm, a saturated solution of butala; on periodontal tissues and hard tissues of the teeth, covered with torontoi saturated solution of butola, impose medical bandage. Method of conservative treatment of inflammatory periodontal diseases is used as follows. Under adequate anesthesia produce professional hygiene of the oral cavity in order to remove dental plaque. Produce multiple irrigation of periodontal tissues with a solution of butola. Made of medical dressing by adding a powder of zinc oxide and zinc sulfate in solution butola and blend them to a paste-like consistency. The firmness of the Dyje tissues of the teeth with vestibular and oral surfaces in the cervical areas covered by torontoy, a saturated solution of butola, with a diameter of 1-4 mm; on periodontal tissues and hard tissues of the teeth, covered with torontoi saturated solution of butola, impose medical bandage.

Using the new method and the results of its application are confirmed by the following clinical examples.

Clinical example 1. Patient O., 42 years. The diagnosis of Chronic generalized periodontitis of moderate severity. It is noted spontaneous bleeding, limitiruyuschie gnetaceae from periodontal pockets. Under local anesthesia Sol. Ultracaini D. S. - 1.8 ml., produced professional hygiene of the teeth on the lower jaw in order to remove dental plaque. Produced multiple irrigation of periodontal tissues with a solution of butola. Manufactured medical bandage by adding a powder of zinc oxide and zinc sulfate in solution butola and blend them to a paste-like consistency. Hard tissues of the teeth with vestibular and oral surfaces in the cervical areas covered by torontoy, with a diameter of 1 mm, a saturated solution of butola. On periodontal tissues and hard tissues of the teeth, covered with torontoi saturated solution of butola imposed medical bandage.

Recommendations are given. Scheduled follow-up visit. After 48 hours, the bandage is removed. Clinically, we observed no spontaneous bleeding. On the 2nd day of the inflammation in the periodontium is lnyh pockets on the lower jaw cropped.

Clinical example 2. Patient N., 50. The diagnosis of Chronic generalized periodontitis of moderate severity. It is noted spontaneous bleeding, limitiruyuschie gnetaceae from periodontal pockets. Under local anesthesia Sol. Ultracaini D. S. - 1.8 ml., produced professional hygiene of the teeth on the upper jaw in order to remove dental plaque. Produced multiple irrigation of periodontal tissues with a solution of butola. Manufactured medical bandage by adding a powder of zinc oxide and zinc sulfate in solution butola and blend them to a paste-like consistency. Hard tissues of the teeth with vestibular and oral surfaces in the cervical areas covered by torontoy, with a diameter of 4 mm, a saturated solution of butola. On periodontal tissues and hard tissues of the teeth, covered with torontoi saturated solution of butola imposed medical bandage.

Recommendations are given. Scheduled follow-up visit. After 48 hours, the bandage is removed. Clinically, we observed no spontaneous bleeding, reduction of sickness. On the day 3 of inflammation in periodontal pockets on the lower jaw cropped. The positive effect from the use of the proposed method is that when the conservative treatment of periodontal disease, the method provides a hemostatic effect, sufficient protivovospalitel the second action, optimal diffusion of the drug into the tissues of the periodontium, provides prolonged effects of medicinal substances on periodontal tissues. The proposed model can be used in dental offices dentistry and outpatient dental settings.

Sources of information

1. RF patent for the invention №2005100857, application No. 2005100857/14 from 17.01.2005.

2. RF patent for the invention №2003105200, application No. 2003105200/14 from 25.02.2003.

3. RF patent for the invention №2480228, application No. 2012115064/15 from 16.04.2012.

4. Operative dentistry: a tutorial: 3 hours / Ed. by G. M. Barrera. - M.: GEOTAR Media, 2009. - 2 hours. - Periodontal diseases. - S. 141-142.

Method of conservative treatment of periodontal disease, including the imposition on periodontal tissues of the medical bandage, prepared on the basis of zinc oxide and zinc sulfate, characterized in that before the imposition of medical bandages repeated irrigation of periodontal tissues with a solution of butala; medical bandage is made by adding a powder of zinc oxide and zinc sulfate in solution butola and blend them to a paste-like consistency; hard tissue of teeth with vestibular and oral surfaces in the cervical areas covered by torontoi diameter of 1-4 mm, a saturated solution of butala; on periodontal tissues and hard tissues of the teeth, covered with torontoi on yennai solution butola, impose a medical bandage.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dentistry. A method of treating inflammatory diseases of parodentium involves administering a dosage form into gingival pockets and immersed fully underneath the gingival line; that is ensured by irrigating the gingival pockets with Dentos solution; an implant side for a medicinal thread is created by placing a retraction thread of a diameter exceeding that of the medicinal thread into the gingival pockets, or the implant side for the medicinal thread is created in the gingival pockets by scaling with an abrasion spoon or a scaler; saturated Dentos cotton medicinal thread or saturated Dentos medicinal resorbed carboxymethyl cellulose thread is introduced into the gingival pockets.

EFFECT: using the method provides the prolonged maintenance of the active substance concentration in the parodontium tissues with the active substance possessing antimicrobial and anti-inflammatory properties, and has a uniform effect along the whole perimeter of the gingival pocket that enables reducing the inflammatory process.

2 ex

FIELD: medicine.

SUBSTANCE: pharmaceutical composition contains recombinant interferon specified in a group: recombinant interferon alpha, recombinant interferon beta, recombinant interferon gamma, metronidazole, hypromellose, antiseptics and a consistency base in the following relation of ingredients, g per 1 ml of the mixture: recombinant interferon, IU 100-10,000,000; metronidazole 0.00001-0.5; hypromellose 0.00001-0.5; antiseptics 0.00001-0.5; consistency base - the rest. Besides, the pharmaceutical composition contains antibiotics specified in a group: baneocin, levomycin, tetracycline, amoxicilline in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains antiseptics specified in a group: boric acid, salicylic acid, hydrogen peroxide, chlorhexidine, ethanol, povidone iodine, silver nitrate, silver sulphadiazine in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains anesthesin or lidocaine as local anaesthetics in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains vitamin A or beta-carotene as food colorants in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains flavouring agents specified in a group of: tea tree oil, menthol oil, eucalyptus leaf oil in an amount of 0.00001-0.5 g. Besides, the pharmaceutical composition contains macrogol 400, or macrogol 1500, or macrogol 4000 as a consistency base.

EFFECT: more effective treatment.

7 cl, 11 ex

FIELD: medicine.

SUBSTANCE: invention represents a therapeutic agent for oral cleaning in individuals suffering xerostomia, possessing antiseptic action and presented as spray, gel and mouthwash, containing a drug, differing by the fact that the drug contains hypromellose, boric acid and a flavour specified in a group: tea tree oil, menthol oil, eucalyptus oil and a consistency base in the following relations, g per 1ml of mixture: hypromellose 0.00001-0.5; boric acid 0.00001-0.5; flavour 0.00001-0.5; consistency base - the rest.

EFFECT: improving the properties of the agent.

2 cl, 6 ex

FIELD: medicine.

SUBSTANCE: method involves preliminary assessment of the reversible abnormal changes of enamel accompanying early cariosity. That is ensured by diagnostic tests of solid dental tissues conducted by using light-induced fluorescence and electrometric measurement techniques followed by therapy involving daily applications of the Radogel-GABA preparation. If observing visually detected changes with a current intensity of 0.21-1.99 mcA in the lesion and the presence of fluorescence, the preclinical changes of enamel are diagnosed requiring 5 therapeutic procedures with the above preparation. Visualised tarnishing of enamel accompanied by a current intensity of 2.00-3.99 mcA in the lesion and the presence of fluorescence, an early carious change of enamel at the stage of a dead spot is diagnosed, and 7 therapeutic procedures are conducted. If visualising a white spot of enamel accompanied by a current intensity of 4.00-5.99 mcA in the lesion and the presence of fluorescence, an early carious change of enamel at the stage of a white spot is diagnosed, and 10 therapeutic procedures are conducted. If visualising a white spot of enamel accompanied by a current intensity of 6.00-7.99 mcA in the lesion and the presence of fluorescence, an early carious change of enamel at the stage of an intense white spot is diagnosed, and 15 therapeutic procedures with the Radogel-GABA preparation are required.

EFFECT: method provides the high-effective therapeutic exposure on caries by the timely recovery of the protein dental matrix with simplicity and ease of use at massive dental visits.

2 tbl

FIELD: medicine.

SUBSTANCE: formulation of initial ingredients of the presented tooth paste for treating and preventing dento-facial inflammatory diseases involves a tissue regeneration stimulator specified in hyaluronic acid or sucralfate, or ε-acetylaminocapronic acid sodium salt, the enzymes lysozyme, papaine and hyaluronidase, as well as an abrasive ingredient, a moistening agent, hydrocolloid, a surfactant, sodium fluoride, tetrapotassium pyrophosphate, a preserving agent, a flavouring agent and water in certain amounts.

EFFECT: effective oral cleaning and removal of plaque, reduced bleeding gum and oral inflammations, faster dento-facial regeneration in the inflammations.

4 cl, 9 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: formulation for the prevention of dental and parodontal diseases comprises inula rhizome and root tea, sodium benzoate, sorbitol, a flavour and water in the following proportions, wt %: inula rhizome and root tea 0.3-20.0; sodium benzoate 0.1-0.3; sorbitol 14.0-35.0; flavour 0.3-2.0; water - the rest. The formulation can be used for a wide circle of patients, including in paediatric dentistry, for people suffering chronic cardiovascular diseases, and for drivers.

EFFECT: pronounced preventive and therapeutic effect, particularly anti-caries and anti-inflammatory one.

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutics and represents a method of treating periodontitis by instillations of the Cholisal gel into the gingival pockets and gingival applications 2-3 times a day for 20 days; the method differs by prescribing the Calcium-vit D3C preparation 1 capsule twice a day for one month, with the therapeutic course repeated 6 months later.

EFFECT: invention provides the higher effectiveness of the method of treating periodontitis by achieving the osteotropic and immunotropic action alongside with the local bactericidal and anti-inflammatory effect.

3 ex, 3 tbl

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dentistry, and can be used for the preventing and treating infectious processes accompanying dental surgeries. That is ensured by intraoperative administration of a therapeutic antibacterial preparation of penicillin and an antibacterial preparation of the third-generation cephalosporin. The above preparation is administered daily for 3-5 postoperative days. The above preparation is administered intra- and post-operatively once a day intravenously drop by drop for 15-35 minutes in a dose of 30-55% of the recommended daily dose.

EFFECT: invention enables reducing a possibility of antibiotic dosage with complete withdrawal of repeated intra- and post-operative one-day administration of the antibiotics, with avoiding the developing early and late postoperative infectious-inflammatory complications.

3 cl, 5 ex

FIELD: medicine.

SUBSTANCE: invention represents a tooth paste for treating and preventing dentoalveolar inflammatory diseases with its initial formulation containing: (0.001-5.0 carbamide ozonide, 0.01-0.5 potassium dihydrophosphate, 0.01-0.5 sodium hydroxide) or (0.001-5.0 calcium pyrrolidone carboxylate, 0.001-2.0 polyethylene glycol chitosan, 0.001-0.5 proline, 0.001-0.5 lysine, 0.001-0.5 arginine) or (0.001-5.0 D-panthenol, 0.001-0.5 magnesium ascorbyl phosphate, 0.001-5.0 sodium hydrocarbonate), 0.01-5.0 lysozyme; 0.01-5.0 papain; 2.00-20.00 abrasive; 5.00-20.88 humidifying agent; 0.05-5.0 hydrocolloid; 0.10-2.00% surfactant; 0.10-0.32 sodium fluoride; 0.50-5.00 tetrapotassium pyrophosphate; 0.15-0.40 preserving agent; 0.05-1.50 flavouring agent; water - the rest.

EFFECT: invention provides normalising saliva and oral fluid pH, reducing inflammations and accelerating the regeneration processes in the dentoalveolar tissues accompanying inflammatory diseases.

4 cl, 10 tbl, 3 ex

FIELD: medicine.

SUBSTANCE: invention aims at treating active chronic generalised gingivitis. What is used is immobilised nimesulide in the form of 20-minute gingival applications for 3-6 days.

EFFECT: method provides higher clinical effectiveness and reduced length of treatment.

1 ex

New composition // 2538718

FIELD: medicine, pharmaceutics.

SUBSTANCE: group of inventions refers to a dental cleaning composition and a method for preparing it. The dental cleaning composition contains calcific aluminium oxide as a polishing agent containing 50 to 90 wt % of aluminium α-oxide and 10.0 to 50 wt % of aluminium γ-oxide in an amount of 0.1 to 3.0 wt % of the total composition, water-soluble tripolyphosphate alkali salt and orally acceptable carrier or excipient with the composition being free from silicone dioxide abrasive. A method for preparing the composition involves mixing the ingredients easily in vacuum to prepare a homogenous mixture and to adjust pH if necessary.

EFFECT: using the composition enables achieving good cleaning, excellent shine and dental surface polishing with low dentine abrasion.

10 cl, 4 ex, 5 dwg

FIELD: medicine.

SUBSTANCE: pharmaceutical composition for treating demodecosis contains metronidazole, tea tree oil, polymer carrier specified in: macrogol 400, macrogol 1,500, macrogol 4,000, and distilled water in certain amounts.

EFFECT: composition treats demodecois effectively, with no side effects.

6 cl, 8 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to dentistry. A method of treating inflammatory diseases of parodentium involves administering a dosage form into gingival pockets and immersed fully underneath the gingival line; that is ensured by irrigating the gingival pockets with Dentos solution; an implant side for a medicinal thread is created by placing a retraction thread of a diameter exceeding that of the medicinal thread into the gingival pockets, or the implant side for the medicinal thread is created in the gingival pockets by scaling with an abrasion spoon or a scaler; saturated Dentos cotton medicinal thread or saturated Dentos medicinal resorbed carboxymethyl cellulose thread is introduced into the gingival pockets.

EFFECT: using the method provides the prolonged maintenance of the active substance concentration in the parodontium tissues with the active substance possessing antimicrobial and anti-inflammatory properties, and has a uniform effect along the whole perimeter of the gingival pocket that enables reducing the inflammatory process.

2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to the pharmaceutical industry, namely to a preparation having the general strengthening and tonic effect. The preparation having the general strengthening and tonic effect produced by infusing the dandelion and robinia blossom in a rolling boil, filtering and heating on a water bath with sugar added, cooling and blending with honey in the certain environment.

EFFECT: preparation has the pronounced general strengthening and tonic effect.

FIELD: medicine.

SUBSTANCE: group of inventions refers to medicine, namely to ophthalmology, and aims at treating eye discomfort. Treating the eye discomfort is ensured by applying a liquid composition containing a cooling agent. The cooling agent represents 2,3-dihydroxypropyl ester of (1R,2S,5R)-2-isopropyl-5-methylcyclohexane carboxylic acid (or CPS-030). The liquid composition of the cooling agent is applied locally on at least a part of the outer surface of the eyelid (preferentially a closed one) to be treated. Preferentially, the liquid composition of the cooling agent is applied on a tissue, a tampon or a wipe or is enclosed into a tissue, a tampon or a wipe, e.g. an eye wipe.

EFFECT: using the group of inventions provides the prolonged relief of the eye discomfort with no eye irritation.

57 cl, 1 tbl, 1 dwg, 6 ex

FIELD: medicine.

SUBSTANCE: method for integrated treatment of hip diseases accompanying a total replacement involves a postoperative background therapy with using an infusion therapy, an antibiotic therapy, an anticoagulant therapy, therapeutic exercises and a physical therapy; aqueous herbal tea containing willow bark, common St.-John's wort herb, balm lemon herb, liquorice root, meadowsweet herb, mountain ash fruit, raspberry leaves taken in certain proportions 14 days before the operation and for three postoperative months in a dose of 0.5 glass 4 times a day half an hour before a meal.

EFFECT: method enables providing the higher effectiveness of the surgical management of hip diseases by improving patient's rehabilitation, promotes reducing trait and state anxieties, a rate of administration of analgesic preparations, improving the motor function of limbs and preventing postoperative complications.

1 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: invention represents a tissue impregnated with a gel composition containing lidocaine hydrochloride, hydrogenated castor oil, dimethylsulphoxide, propylene glycol, benzyl alcohol, and water, wherein the ingredients are taken in the composition in certain proportions, wt %.

EFFECT: high disinfectant and protective effect; provides high sexual activity and a possibility to prolong a coitus.

4 cl, 3 ex

FIELD: medicine.

SUBSTANCE: treating tonsillopharyngitis in children is ensured by Panavir Inlight spray gel 1 oropharyngeal irrigation 2 times a day after meal daily for 5 days.

EFFECT: method enables treating more effectively by the anti-viral and cytoprotective action of the preparation, reducing a toxic load with no complications and applicability.

4 ex

FIELD: food industry.

SUBSTANCE: biologically active food additive strengthening the organism adaptive power and body defences and having anti-inflammatory and antioxidant activity contains vegetal origin components represented by a complex extract of devil's-club root, Rhaponticum carthamoides root, Hedysarum neglectum Ledeb root, celery roots and leaves, rhodiola rosea root, Japanese angelica tree roots, boschniakia rossica roots, Hungarian sainfoin herb, magnolia-vine fruits; additionally the additive contains chitosan, trepang fermentative hydrolysate, ascorbic acid, taurine, glutathione, nicotinamide, vitamin B1, vitamin B2, vitamin B6, vitamin B12, folic acid, anhydrous calcium chloride, magnesium chloride, zinc chloride, bee honey at preset ingredients ratio.

EFFECT: biologically active food additive promotes effective strengthening of the organism adaptive power and body defences and human aging retardation.

4 tbl, 6 ex

FIELD: pharmacology.

SUBSTANCE: invention relates to compositions from green tea, stabilised by natural antioxidants, such as oligomer procyanidins (OPC) together with vitamin C or analogues of vitamin C. It is proposed to use a mixture of OPC and ascorbic acid for improved bioavailability of green tea catechines. The method includes a stage of using the composition containing a green tea catechine and a mixture of oligomer procyanidins (OPC) and ascorbic acid or analogues of the vitamin C.

EFFECT: increased bioavailability of catechines in food or cosmetic compositions.

12 cl, 4 dwg, 11 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: invention represents an agent for preventing and treating prostatitis and prostate adenoma in the form of a capsule, which contains doxazosin, diisopropylammonium dichroloacetate, afobazol, copper glycinate, vitamin E (d-alpha tocopherol acetate), zinc glycinate; L-Glutamine; L-Alanine; L-Arginine and excipients: corn starch and talc.

EFFECT: extended range of products for treating and preventing prostatitis and prostate adenoma.

4 ex, 3 tbl

Up!